Medical Microinstruments announced today that the FDA granted de novo clearance for its Symani surgical robot platform. Clearance covers soft tissue manipulation to perform microsurgery. This technique involves reconnecting tiny vessels to restore blood flow or redirect fluid during reconstruction or repair. FDA authorization makes Symani the only commercially available platform in the U.S. for […]
MMI
Medical Microinstruments expands global footprint to Asia Pacific market
Medical Microinstruments announced today that it inked distribution agreements covering nearly a dozen countries in the Asia Pacific region. The company aims to continue its global momentum with a new footprint expansion in APAC. Its first partnership, struck with Device Technologies, helps bring its surgical robot to a number of countries. This brings the Symani […]
MMI surgical robot surpasses 500 clinical cases
Medical Microinstruments (MMI) today announced the successful completion of more than 500 in-human surgeries with its surgical robot. The Symani system aims to address the challenges of microsurgery with its NanoWrist instruments. These instruments help to access and suture small, delicate anatomies. That includes veins, arteries, nerves and lymphatic vessels as small as 0.3mm in […]
MMI wins CE Mark for robotic microsurgery system
MMI SpA announced today that it received CE Mark for and launched its Symani surgical system for open microsurgical procedures. Calci, Italy-based MMI’s Symani system also experienced its first human use, having been used in four successful robotic surgeries performed in Florence, Italy. Three of those procedures were complex, post-traumatic lower limb reconstructions, with one […]